Intuitive Surgical, Inc. (NASDAQ:ISRG) Short Interest Update

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) saw a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 3,740,000 shares, an increase of 10.3% from the July 31st total of 3,390,000 shares. Based on an average daily trading volume, of 1,520,000 shares, the days-to-cover ratio is presently 2.5 days.

Insider Buying and Selling at Intuitive Surgical

• 3 Best Growth Stocks to Own for the Next 10 Years

In other Intuitive Surgical news, EVP Robert Desantis sold 239 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $416.60, for a total value of $99,567.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,293,799.60. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Robert Desantis sold 239 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company's stock, valued at $2,293,799.60. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 55,552 shares of company stock worth $26,281,657. 0.90% of the stock is owned by insiders.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors have recently modified their holdings of the company. Advisors Asset Management Inc. grew its stake in shares of Intuitive Surgical by 18.1% in the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider's stock valued at $2,945,000 after buying an additional 1,129 shares in the last quarter. Provence Wealth Management Group acquired a new position in Intuitive Surgical during the 4th quarter worth $276,000. Public Employees Retirement System of Ohio grew its stake in Intuitive Surgical by 5.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider's stock worth $64,531,000 after purchasing an additional 9,869 shares in the last quarter. HCR Wealth Advisors lifted its holdings in Intuitive Surgical by 26.3% during the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider's stock worth $352,000 after buying an additional 217 shares during the last quarter. Finally, Checchi Capital Advisers LLC lifted its holdings in Intuitive Surgical by 2.5% during the 4th quarter. Checchi Capital Advisers LLC now owns 2,875 shares of the medical equipment provider's stock worth $970,000 after buying an additional 70 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

• Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs

Shares of Intuitive Surgical stock opened at $492.63 on Friday. Intuitive Surgical has a one year low of $254.85 and a one year high of $493.97. The company has a market cap of $174.74 billion, a price-to-earnings ratio of 88.92, a PEG ratio of 4.97 and a beta of 1.39. The business's 50 day moving average price is $454.69 and its 200 day moving average price is $414.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to analysts' expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm's quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.18 earnings per share. On average, analysts predict that Intuitive Surgical will post 5.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

• Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?

A number of research analysts have recently weighed in on ISRG shares. BTIG Research increased their price objective on Intuitive Surgical from $469.00 to $494.00 and gave the company a "buy" rating in a report on Wednesday. Stifel Nicolaus increased their price objective on Intuitive Surgical from $430.00 to $475.00 and gave the company a "buy" rating in a report on Friday, July 19th. Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. Piper Sandler increased their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the company an "overweight" rating in a report on Friday, July 19th. Finally, Redburn Atlantic raised Intuitive Surgical from a "neutral" rating to a "buy" rating and raised their target price for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $446.45.

Check Out Our Latest Stock Report on Intuitive Surgical

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

• Five stocks we like better than Intuitive Surgical
• Investing In Automotive Stocks
• Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
• Best Stocks Under $5.00
• MarketBeat Week in Review – 8/26 - 8/30
• Why Are These Companies Considered Blue Chips?
• Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ The $15 "Insider Secret" That Could Save Your Retirement (From Behind the Markets) (Ad)

Should you invest $1,000 in Intuitive Surgical right now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here